MediYoga compared to physiotherapy treatment as usual for patients with stress-related symptoms in primary care rehabilitation: A randomized controlled trial
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0300756 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Madeleine Bellfjord und 2 weiteren Autor:innen. Beteiligte Einrichtung: Region Västra Götaland, Department of Rehabilitation, Närhälsan Clinic in Primary Care, Gibraltarg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Physical Therapy Modalities, Stress, Psychological, Primary Health Care. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MB VGFOUGSB The Local Research and Development Council Gothenburg and Södra Bohuslän..
Abstract (Originalsprache)
Objective
The purpose of this study was to compare the effect of MediYoga as a group treatment to conventional treatment provided by a physiotherapist for people with perceived stress-related symptoms.
Design
Randomized controlled trial. Settings Primary care rehabilitation, Gothenburg Sweden. Subjects Fifty-five patients with stress-related symptoms were invited to participate. Nine patients declined, and a total of 46 patients aged 26–70 years (mean 47), 44 women and two men were randomized, 23 to the MediYoga group and 23 to the physiotherapy treatment as usual group.
Interventions
The MediYoga group performed MediYoga for one hour a week during an 8-week period. The control group received physiotherapy treatment as usual. Main measures Data were mainly collected by self-reported questionnaires. For primary outcome the Swedish version of the Perceived Stress Scale (PSS) was used. Secondary outcomes were the Hospital Anxiety and Depression Scale (HADS), EuroQol–5D (EQ-5D) and EuroQol–Visual Analog Scale (EQ-VAS). Thoracic excursion was the only physical measurement. Mixed effect model was used for analyse.
Results
For the primary outcome PSS, there was a close to statistically significant group effect over time advantaging MediYoga over physiotherapy ( P = 0.06). For secondary outcomes, the group effect over time was statistically significant in HADS anxiety ( P = 0.01) and EQ-VAS (P = 0.03). There was a group trend over time advantaging MediYoga in HADS depression ( P = 0.08).
Conclusion
Despite a large dropout in both groups, MediYoga can be recommended as a treatment option for people suffering from stress-related symptoms.
Trial registration
Registered in: ClinicalTrials.gov NCT02907138
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Region Västra Götaland, Department of Rehabilitation, Närhälsan Clinic in Primary Care, Gibraltarg, Gothenburg, Sweden.
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Research, Education, Development and Innovation Primary Health Care, Region Västra Götaland, Gothenburg, Sweden.
- Department of Health and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Madeleine Bellfjord, Maria E H Larsson
Förderung
- MB VGFOUGSB The Local Research and Development Council Gothenburg and Södra Bohuslän.
Zitieren
APA
Bellfjord, M., Grimby-Ekman, A., & Larsson, M. E. H. (2024). MediYoga compared to physiotherapy treatment as usual for patients with stress-related symptoms in primary care rehabilitation: A randomized controlled trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0300756
Vancouver
Bellfjord M, Grimby-Ekman A, Larsson MEH. MediYoga compared to physiotherapy treatment as usual for patients with stress-related symptoms in primary care rehabilitation: A randomized controlled trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0300756
BibTeX
@article{Bellfjord2024,
author = {Bellfjord, Madeleine and Grimby-Ekman, Anna and Larsson, Maria E H},
title = {MediYoga compared to physiotherapy treatment as usual for patients with stress-related symptoms in primary care rehabilitation: A randomized controlled trial},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0300756}
}
EUVIMED